Perforated peptic ulcer and short-term mortality among tramadol users

British Journal of Clinical Pharmacology

Volumn 65, Issue 4, 2008, Pages 565-572

  Tørring, Marie L ^a,b   Riis, Anders ^a   Christensen, Steffen ^a   Thomsen, Reimar W ^a   Jepsen, Peter ^a   Søndergaard, Jens ^b   Sørensen, Henrik T ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Anti inflammatory agents; Mortality; Nonsteroidal; Peptic ulcer perforation; Tramadol

Indexed keywords

ACETYLSALICYLIC ACID; GLUCOCORTICOID; NONSTEROID ANTIINFLAMMATORY AGENT; TRAMADOL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG INDICATION; DRUG USE; FEMALE; GASTROINTESTINAL SYMPTOM; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PAIN; PEPTIC ULCER; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; SYMPTOM; ULCER PERFORATION;

AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DENMARK; DRUG ADMINISTRATION SCHEDULE; DUODENAL ULCER; FEMALE; HUMANS; MALE; PEPTIC ULCER PERFORATION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; STOMACH ULCER; SURVIVAL RATE; TRAMADOL;

EID: 40549123046     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.03038.x     Document Type: Article

References (26)

1. Irvin TT. Mortality and perforated peptic ulcer: a case for risk stratification in elderly patients. Br J Surg 1989 76 : 215 8.
2. Wakayama T, Ishizaki Y, Mitsusada M, Takahashi S, Wada T, Fukushima Y, Hattori H, Okuyama T, Funatsu H. Risk factors influencing the short-term results of gastroduodenal perforation. Surg Today 1994 24 : 681 7.
3. Svanes C. Trends in perforated peptic ulcer: incidence, etiology, treatment, and prognosis. World J Surg 2000 24 : 277 83.
4. Testini M, Portincasa P, Piccinni G, Lissidini G, Pellegrini F, Greco L. Significant factors associated with fatal outcome in emergency open surgery for perforated peptic ulcer. World J Gastroenterol 2003 9 : 2338 40.
5. Henry D, Lim LL, Garcia Rodriguez LA, Perez GS, Carson JL, Griffin M, Savage R, Logan R, Moride Y, Hawkey C, Hill S, Fries JT. Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis. BMJ 1996 312 : 1563 6.
6. Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med 1991 115 : 787 96.
7. Thomsen RW, Riis A, Munk EM, Nørgaard M, Christensen S, Sørensen HT. 30-day mortality after peptic ulcer perforation among users of newer selective Cox-2 inhibitors and traditional NSAIDs: a population-based study. Am J Gastroenterol 2006 101 : 2704 10.
8. Danish Medicines Agency. Report [Consumption of strong analgesic drugs (opioids) in primary care- Denmark 1999-2003]. Available at http://www. laegemiddelstyrelsen.dk/publikationer/netpub/forbrugsanalyser/opioid/ (last accessed: 18 September 2007).
9. Wilcox J. Gastrointestinal considerations in patients with cardiovascular disease using nonopioid analgesics for mild-to-moderate pain or cardioprotection. Am J Cardiol 2006 97 (9 Suppl. 1 17 22.
10. Recommendations for the appropriate use of opioids in persistent non-cancer pain. A consensus statement prepared on behalf of the Pain Society, the Royal College of Anaesthetists, the Royal College of General Practitioners and the Royal College of Psychiatrists. London : The Pain Society, March 2004. Available at http://www.britishpainsociety.org/book_opioid_main.pdf (last accessed: 18 September 2007).
11. Kalso E, Allan L, Dellemijn PL, Faura CC, Ilias WK, Jensen TS, Perrot S, Plaghki LH, Zenz M. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain 2003 7 : 381 6.
12. Goodwin JL, Kraemer JJ, Bajwa ZH. The use of opioids in the treatment of osteoarthritis: when, why, and how? Curr Pain Headache Rep 2005 9 : 390 8.
13. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000 43 : 1905 15.
14. Budd K. Pain management: is opioid immunosuppression a clinical problem? Biomed Pharmacother 2006 60 : 310 7.
15. Christensen S, Riis A, Nørgaard M, Thomsen RW, Tønnesen EM, Larsson A, Sørensen HT. Perforated peptic ulcer: use of pre-admission oral glucocorticoids and 30-day mortality. Aliment Pharmacol Ther 2006 23 : 45 52.
16. Thomsen RW, Riis A, Christensen S, Nørgaard M, Sørensen HT. Diabetes and 30-day mortality from peptic ulcer bleeding and perforation: a Danish population-based cohort study. Diabetes Care 2006 29 : 805 10.
17. Nickelsen TN. [Data validity and coverage in the Danish National Health Registry. A literature review]. Ugeskr Laeger 2002 164 : 33 7.
18. Lassen A, Hallas J, Schaffalitzky de Muckadell OB. Complicated and uncomplicated peptic ulcers in a Danish county 1993-2002: a population-based cohort study. Am J Gastroenterol 2006 101 : 945 53.
19. Jarernsiripornkul N, Krska J, Richards RM, Capps PA. Patient reporting of adverse drug reactions: useful information for pain management? Eur J Pain 2003 7 : 219 24.
20. Signorello LB, McLaughlin JK, Lipworth L, Friis S, Sørensen HT, Blot WJ. Confounding by indication in epidemiologic studies of commonly used analgesics. Am J Ther 2002 9 : 199 205.
21. Dubois RW, Melmed GY, Henning JM, Laine L. Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy. Aliment Pharmacol Ther 2004 19 : 197 208.
22. Fendrick A, Garabedian-Ruffalo S. A clinician's guide to the selection of NSAID therapy. Pharm Ther 2002 27 : 579 80, 582.
23. Schnitzer TJ. Non-NSAID pharmacologic treatment options for the management of chronic pain. Am J Med 1998 105 : 45S 52S.
24. Sacerdote P, Bianchi M, Gaspani L, Manfredi B, Maucione A, Terno G, Ammatuna M, Pancrai AE. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg 2000 90 : 1411 4.
25. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987 40 : 373 83.
26. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992 45 : 613 9.